233 related articles for article (PubMed ID: 8122270)
1. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity and lymphocyte subpopulations: differences between mice and rats.
Smialowicz RJ; Riddle MM; Williams WC; Diliberto JJ
Toxicol Appl Pharmacol; 1994 Feb; 124(2):248-56. PubMed ID: 8122270
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of lymphocyte subpopulations in the spleen and thymus of mice exposed to an acute immunosuppressive dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Kerkvliet NI; Brauner JA
Environ Res; 1990 Aug; 52(2):146-54. PubMed ID: 2118453
[TBL] [Abstract][Full Text] [Related]
3. Opposite effects of 2,2',4,4',5,5'-hexachlorobiphenyl and 2,3,7,8-tetrachlorodibenzo-p-dioxin on the antibody response to sheep erythrocytes in mice.
Smialowicz RJ; DeVito MJ; Riddle MM; Williams WC; Birnbaum LS
Fundam Appl Toxicol; 1997 Jun; 37(2):141-9. PubMed ID: 9242587
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the T cell-independent antibody response of mice and rats exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Smialowicz RJ; Williams WC; Riddle MM
Fundam Appl Toxicol; 1996 Aug; 32(2):293-7. PubMed ID: 8921333
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of the SRBC PFC assay versus ELISA for detection of immunosuppression by TCDD and TCDD-like congeners.
Johnson CW; Williams WC; Copeland CB; DeVito MJ; Smialowicz RJ
Toxicology; 2000 Dec; 156(1):1-11. PubMed ID: 11162871
[TBL] [Abstract][Full Text] [Related]
6. CYP1A2 is not required for 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced immunosuppression.
Smialowicz RJ; Burgin DE; Williams WC; Diliberto JJ; Setzer RW; Birnbaum LS
Toxicology; 2004 Apr; 197(1):15-22. PubMed ID: 15003330
[TBL] [Abstract][Full Text] [Related]
7. Repeated high dose oral exposure or continuous subcutaneous infusion of 2-methoxyacetic acid does not suppress humoral immunity in the mouse.
Riddle MM; Williams WC; Smialowicz RJ
Toxicology; 1996 May; 109(1):67-74. PubMed ID: 8619254
[TBL] [Abstract][Full Text] [Related]
8. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induction of cytochrome P450-dependent arachidonic acid metabolism in mouse liver microsomes: evidence for species-specific differences in responses.
Lee CA; Lawrence BP; Kerkvliet NI; Rifkind AB
Toxicol Appl Pharmacol; 1998 Nov; 153(1):1-11. PubMed ID: 9875294
[TBL] [Abstract][Full Text] [Related]
9. Characterization of protein phosphorylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in murine lymphocytes: indirect evidence for a role in the suppression of humoral immunity.
Snyder NK; Kramer CM; Dooley RK; Holsapple MP
Drug Chem Toxicol; 1993; 16(2):135-63. PubMed ID: 8486096
[TBL] [Abstract][Full Text] [Related]
10. Interactions of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) with immune responses of rainbow trout.
Spitsbergen JM; Schat KA; Kleeman JM; Peterson RE
Vet Immunol Immunopathol; 1986 Jun; 12(1-4):263-80. PubMed ID: 3765346
[TBL] [Abstract][Full Text] [Related]
11. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on humoral and cell-mediated immunity in Sprague-Dawley rats.
Fan F; Wierda D; Rozman KK
Toxicology; 1996 Jan; 106(1-3):221-8. PubMed ID: 8571394
[TBL] [Abstract][Full Text] [Related]
12. Immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in a complex environmental mixture from the Love Canal.
Silkworth JB; Cutler DS; Sack G
Fundam Appl Toxicol; 1989 Feb; 12(2):303-12. PubMed ID: 2714530
[TBL] [Abstract][Full Text] [Related]
13. TCDD-mediated suppression of the in vitro anti-sheep erythrocyte IgM antibody forming cell response is reversed by interferon-gamma.
North CM; Kim BS; Snyder N; Crawford RB; Holsapple MP; Kaminski NE
Toxicol Sci; 2009 Jan; 107(1):85-92. PubMed ID: 18948302
[TBL] [Abstract][Full Text] [Related]
14. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.
Diliberto JJ; Akubue PI; Luebke RW; Birnbaum LS
Toxicol Appl Pharmacol; 1995 Feb; 130(2):197-208. PubMed ID: 7871533
[TBL] [Abstract][Full Text] [Related]
15. Acute inflammatory response to sheep red blood cell challenge in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): phenotypic and functional analysis of peritoneal exudate cells.
Kerkvliet NI; Oughton JA
Toxicol Appl Pharmacol; 1993 Apr; 119(2):248-57. PubMed ID: 8480333
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the developing immune system of the F344 rat after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: II. Effects on the pup and the adult.
Gehrs BC; Riddle MM; Williams WC; Smialowicz RJ
Toxicology; 1997 Oct; 122(3):229-40. PubMed ID: 9328223
[TBL] [Abstract][Full Text] [Related]
17. Differential time-course and dose-response relationships of TCDD-induced CYP1B1, CYP1A1, and CYP1A2 proteins in rats.
Santostefano MJ; Ross DG; Savas U; Jefcoate CR; Birnbaum LS
Biochem Biophys Res Commun; 1997 Apr; 233(1):20-4. PubMed ID: 9144388
[TBL] [Abstract][Full Text] [Related]
18. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.
Tritscher AM; Goldstein JA; Portier CJ; McCoy Z; Clark GC; Lucier GW
Cancer Res; 1992 Jun; 52(12):3436-42. PubMed ID: 1596902
[TBL] [Abstract][Full Text] [Related]
19. Influence of the Ah locus on the humoral immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: evidence for Ah-receptor-dependent and Ah-receptor-independent mechanisms of immunosuppression.
Kerkvliet NI; Steppan LB; Brauner JA; Deyo JA; Henderson MC; Tomar RS; Buhler DR
Toxicol Appl Pharmacol; 1990 Aug; 105(1):26-36. PubMed ID: 2168100
[TBL] [Abstract][Full Text] [Related]
20. alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression.
Blank JA; Tucker AN; Sweatlock J; Gasiewicz TA; Luster MI
Mol Pharmacol; 1987 Jul; 32(1):169-72. PubMed ID: 3037301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
